576 related articles for article (PubMed ID: 25625286)
1. Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test.
Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
PLoS One; 2015; 10(1):e0115787. PubMed ID: 25625286
[TBL] [Abstract][Full Text] [Related]
2. Impact of GOLD groups of chronic pulmonary obstructive disease on surgical complications.
Kim HJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Choi SM
Int J Chron Obstruct Pulmon Dis; 2016; 11():281-7. PubMed ID: 26929613
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.
Chun EM; Kim SW; Lim SY
Int J Chron Obstruct Pulmon Dis; 2015; 10():955-60. PubMed ID: 26028968
[TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study.
Bárbara C; Rodrigues F; Dias H; Cardoso J; Almeida J; Matos MJ; Simão P; Santos M; Ferreira JR; Gaspar M; Gnatiuc L; Burney P
Rev Port Pneumol; 2013; 19(3):96-105. PubMed ID: 23664024
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.
Raluy-Callado M; Lambrelli D; MacLachlan S; Khalid JM
Int J Chron Obstruct Pulmon Dis; 2015; 10():925-37. PubMed ID: 25999708
[TBL] [Abstract][Full Text] [Related]
8. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
[TBL] [Abstract][Full Text] [Related]
9. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in Jordan.
Al Omari M; Khassawneh BY; Khader Y; Dauod AS; Bergus G
Int J Chron Obstruct Pulmon Dis; 2014; 9():753-8. PubMed ID: 25092972
[TBL] [Abstract][Full Text] [Related]
12. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease.
Shirtcliffe P; Marsh S; Travers J; Weatherall M; Beasley R
Intern Med J; 2012 Jan; 42(1):83-8. PubMed ID: 20403069
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
Echave-Sustaeta JM; Comeche Casanova L; Cosio BG; Soler-Cataluña JJ; Garcia-Lujan R; Ribera X
Int J Chron Obstruct Pulmon Dis; 2014; 9():1307-14. PubMed ID: 25429213
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M
Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population.
Zhang J; Zhou JB; Lin XF; Wang Q; Bai CX; Hong QY
Respirology; 2013 Feb; 18(2):297-302. PubMed ID: 23051099
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a claims-based prediction model for COPD severity.
Macaulay D; Sun SX; Sorg RA; Yan SY; De G; Wu EQ; Simonelli PF
Respir Med; 2013 Oct; 107(10):1568-77. PubMed ID: 23806285
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.
Lindberg A; Jonsson AC; Rönmark E; Lundgren R; Larsson LG; Lundbäck B
Respiration; 2005; 72(5):471-9. PubMed ID: 16210885
[TBL] [Abstract][Full Text] [Related]
19. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
[TBL] [Abstract][Full Text] [Related]
20. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
